Karyopharm Therapeutics Inc. - KPTI
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 02, 2026 | Chief Accounting Officer | S | D | 19.0 | 2.02 | 38.38 | 23,782.0 | View | |
| Jul 30, 2026 | EVP, Chief Development Officer | S | D | 189.0 | 7.1 | 1,341.9 | 94,632.0 | View | |
| May 26, 2026 | — | A | A | 15,508.0 | 0.0 | 0.0 | 15,508.0 | View | |
| May 26, 2026 | — | A | A | 15,508.0 | 0.0 | 0.0 | 15,508.0 | View | |
| May 26, 2026 | — | A | A | 15,508.0 | 0.0 | 0.0 | 15,508.0 | View | |
| May 26, 2026 | — | A | A | 15,508.0 | 0.0 | 0.0 | 15,508.0 | View | |
| May 26, 2026 | — | A | A | 15,508.0 | 0.0 | 0.0 | 18,517.0 | View | |
| May 26, 2026 | — | A | A | 15,508.0 | 0.0 | 0.0 | 16,415.0 | View | |
| May 15, 2026 | EVP, Chief Development Officer | S | D | 403.0 | 9.5 | 3,828.5 | 94,821.0 | View | |
| May 15, 2026 | EVP, Chief Development Officer | A | A | 896.0 | 0.0 | 0.0 | 95,224.0 | View | |
| May 15, 2026 | EVP & Chief Medical Officer | S | D | 408.0 | 9.5 | 3,876.0 | 56,829.0 | View | |
| May 15, 2026 | EVP & Chief Medical Officer | A | A | 947.0 | 0.0 | 0.0 | 57,237.0 | View | |
| May 15, 2026 | EVP & Chief Commercial Officer | S | D | 324.0 | 9.5 | 3,078.0 | 107,940.0 | View | |
| May 15, 2026 | EVP & Chief Commercial Officer | A | A | 947.0 | 0.0 | 0.0 | 108,264.0 | View | |
| May 15, 2026 | Chief Accounting Officer | S | D | 53.0 | 9.5 | 503.5 | 23,801.0 | View | |
| May 15, 2026 | Chief Accounting Officer | A | A | 121.0 | 0.0 | 0.0 | 23,854.0 | View | |
| May 15, 2026 | President and CEO | S | D | 2,203.0 | 9.5 | 20,928.5 | 269,747.0 | View | |
| May 15, 2026 | President and CEO | A | A | 4,920.0 | 0.0 | 0.0 | 271,950.0 | View | |
| May 15, 2026 | EVP, CLO&Secretary | S | D | 266.0 | 9.5 | 2,527.0 | 94,398.0 | View | |
| May 15, 2026 | EVP, CLO&Secretary | A | A | 700.0 | 0.0 | 0.0 | 94,664.0 | View | |
| Apr 22, 2026 | EVP & Chief Medical Officer | S | D | 449.0 | 8.94 | 4,014.06 | 56,290.0 | View |